Compare CLNN & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLNN | PCM |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | United States |
| Employees | 79 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 82.0M |
| IPO Year | N/A | N/A |
| Metric | CLNN | PCM |
|---|---|---|
| Price | $6.36 | $5.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $33.75 | N/A |
| AVG Volume (30 Days) | ★ 68.2K | 53.7K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $19,516.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.25 | $5.48 |
| 52 Week High | $13.50 | $6.76 |
| Indicator | CLNN | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 62.41 |
| Support Level | $5.39 | $5.65 |
| Resistance Level | $6.63 | $5.83 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 83.73 | 78.38 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.